Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • ADME/DMPK in the development a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors

ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors

Editorial

Bibliographic Details
Main Authors: Godefridus J. Peters, Kin Tam
Format: Article
Language:English
Published: International Association of Physical Chemists (IAPC) 2016-10-01
Series:ADMET and DMPK
Online Access:http://pub.iapchem.org/ojs/index.php/admet/article/view/348
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://pub.iapchem.org/ojs/index.php/admet/article/view/348

Similar Items

  • Evolutionary divergence in the conformational landscapes of tyrosine vs serine/threonine kinases
    by: Joan Gizzio, et al.
    Published: (2022-12-01)
  • Cross-phosphorylation of bacterial serine/threonine and tyrosine protein kinases on key regulatory residues
    by: Lei eShi, et al.
    Published: (2014-09-01)
  • One year in circulation – an exciting journey for ADMET & DMPK
    by: Kin Tam
    Published: (2013-12-01)
  • Prevention of pulmonary vascular and myocardial remodeling by the combined tyrosine and serine-/threonine kinase inhibitor, sorafenib, in pulmonary hypertension and right heart failure
    by: M. Klein, et al.
    Published: (2008-06-01)
  • Subcellular localization of several structurally different tyrosine kinase inhibitors
    by: Richard Honeywell, et al.
    Published: (2018-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs